Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Theratechnologies Inc.

    NASDAQ: THTX · Real-Time Price · USD
    2.40
    -0.08 (-3.23%)
    At close: Jun 16, 2025, 3:59 PM
    2.38
    -1.04%
    After-hours: Jun 16, 2025, 07:59 PM EDT

    Theratechnologies Statistics

    Share Statistics

    Theratechnologies has 45.98M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 45.98M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 28.2%

    Shares Floating

    n/a
    		 36.33M

    Failed to Deliver (FTD) Shares

    n/a
    		 148

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 245.38K, so 0.53% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 245.38K

    Short % of Shares Out

    n/a
    		 0.53%

    Short % of Float

    n/a
    		 0.78%

    Short Ratio (days to cover)

    n/a
    		 1.93

    Valuation Ratios

    The PE ratio is -7.19 and the forward PE ratio is 8.53. Theratechnologies's PEG ratio is 0.09.

    PE Ratio

    n/a
    		 -7.19

    Forward PE

    n/a
    		 8.53

    PS Ratio

    n/a
    		 0.7

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 -2.36

    P/FCF Ratio

    n/a
    		 67.95

    PEG Ratio

    n/a
    		 0.09
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Theratechnologies.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.19, with a Debt / Equity ratio of -1.8.

    Current Ratio

    n/a
    		 1.19

    Quick Ratio

    n/a
    		 1.05

    Debt / Equity

    n/a
    		 -1.8

    Debt / EBITDA

    n/a
    		 8.82

    Debt / FCF

    n/a
    		 51.88

    Interest Coverage

    n/a
    		 0.78

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $833,650.49

    Profits Per Employee

    n/a
    		 $-80,640.78

    Employee Count

    n/a
    		 103

    Asset Turnover

    n/a
    		 1.61

    Inventory Turnover

    n/a
    		 3.88

    Taxes

    Income Tax

    n/a
    		 2M

    Effective Tax Rate

    n/a
    		 -31.82%

    Stock Price Statistics

    The stock price has increased by 86.05% in the last 52 weeks. The beta is 0.89, so Theratechnologies's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.89

    52-Week Price Change

    n/a
    		 86.05%

    50-Day Moving Average

    n/a
    		 2.52

    200-Day Moving Average

    n/a
    		 1.73

    Relative Strength Index (RSI)

    n/a
    		 38

    Average Volume (20 Days)

    n/a
    		 3,015,714

    Income Statement

    In the last 12 months, Theratechnologies had revenue of 85.87M and earned -8.31M in profits. Earnings per share was -0.17.

    Revenue

    n/a
    		 85.87M

    Gross Profit

    n/a
    		 65.42M

    Operating Income

    n/a
    		 8.17M

    Net Income

    n/a
    		 -8.31M

    EBITDA

    n/a
    		 5.17M

    EBIT

    n/a
    		 4.12M

    Earnings Per Share (EPS)

    n/a
    		 -0.17
    Full Income Statement

    Balance Sheet

    The company has 5.9M in cash and 45.61M in debt, giving a net cash position of -39.71M.

    Cash & Cash Equivalents

    n/a
    		 5.9M

    Total Debt

    n/a
    		 45.61M

    Net Cash

    n/a
    		 -39.71M

    Retained Earnings

    n/a
    		 -416.89M

    Total Assets

    n/a
    		 56.45M

    Working Capital

    n/a
    		 2.67M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 2.38M and capital expenditures -1.5M, giving a free cash flow of 879K.

    Operating Cash Flow

    n/a
    		 2.38M

    Capital Expenditures

    n/a
    		 -1.5M

    Free Cash Flow

    n/a
    		 879K

    FCF Per Share

    n/a
    		 0.02
    Full Cash Flow Statement

    Margins

    Gross margin is 76.19%, with operating and profit margins of 9.52% and -9.67%.

    Gross Margin

    n/a
    		 76.19%

    Operating Margin

    n/a
    		 9.52%

    Pretax Margin

    n/a
    		 -7.34%

    Profit Margin

    n/a
    		 -9.67%

    EBITDA Margin

    n/a
    		 6.02%

    EBIT Margin

    n/a
    		 9.52%

    FCF Margin

    n/a
    		 1.02%

    Dividends & Yields

    THTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for THTX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 31, 2023. It was a backward split with a ratio of 1:4.

    Last Split Date

    n/a
    		 Jul 31, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:4

    Scores

    Altman Z-Score

    n/a
    		 -7.44

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist